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Abstract
Problem—Uterine natural killer cells (uNK) have been thought to play a key role in
endometriosis and infertility. We investigated the expression of CD56, CD16 and NKp46 in
endometrial tissues from 61 women with unexplained recurrent pregnancy loss (uRPL) or
infertility (UI), and correlated this with the presence or absence of endometriosis. The results from
the patients with sub-fertility were compared to those from 10 fertile patients.
Method of study—Mid-secretory phase endometrial biopsies were obtained and the endometrial
expression of CD56, CD16 or NKp46 was identified by immunohistochemistry and quantified
(ImageJ Software).
Results—The percentage of CD16+ cells was higher in women with uRPL (7.9±3.2) and UI
(9.0±5.5), even when these conditions were associated with endometriosis (8.9±5.3), compared to
fertile patients (5.6±2.4, p<0.05). Likewise, the ratio of NKp46+:CD56+ cells was higher in
women with uRPL (0.28±0.25) and UI (0.21±0.2), even when these conditions were associated
with endometriosis (0.19±0.14), compared to fertile patients (0.1±0.1, p<0.05). No differences
were observed when comparing CD56.
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Conclusions—Women, with or without endometriosis, who have larger populations of
cytotoxic CD16+ uNK cells and/or higher populations of NKp46+CD56+ cells may be at greater
risk for infertility disorders resulting from an inflammtory environment occuring during
implantation or later during decidualization.
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Introduction
Uterine natural killer cells (uNK) are the predominant leukocyte population in normal
human endometrium 1. Their content varies throughout the normal menstrual cycle, likely
due to recruitment of peripheral NK cells (pNK) and/or in utero proliferation/differentiation
of stem uNK cells. They represent 40% of the total leukocyte population during the
proliferative phase which increases to 60% by mid-secretory phase and up to 75% in early
pregnancy 2.
Approximately 70–80% of uNK cells are characterized as CD56brightCD16− 3. Activated
uNK cells can produce angiogenic factors (VEGF, ANG2) that promote spiral artery
remodeling, secrete cytokines (GM-CSF, CSF-1, TNFα, INFγ, TGFβ, LIF, IL2, CXCL10,
CXL12) that direct the migration and invasion of the trophoblast, and interact directly with
trophoblast antigens by expressing surface receptors such as killer immunoglobulin-like
receptor (KIR) and immunoglobulin-like transcript-2 (ILT2) 4,5,6. The activity of uNK cells
is controlled by inhibitory receptors such as NKG2a and activating receptors such as NKp30
and NKp46 7. On the other hand, another minor subpopulation of uNK cells, characterized
as CD56dimCD16+, displays cytotoxic activity towards the extravillous trophoblast and
autologous endometrial cells and may create a hostile environment for implantation 8.
Dysregulation of uNK number and/or cell function (cytotoxicity, receptor expression,
cytokine secretion or gene expression) has been associated with reproductive disorders such
as unexplained infertility (UI), unexplained recurrent pregnancy loss (uRPL), and pre-
eclampsia; however studies have been limited to relatively small populations of women and
some findings have been apparently contradictory. For example, while some previous case-
control studies report a higher concentration of uNK cells in women with uRPL compared to
fertile women 9,10,11,12,13, other studies did not find this association 5,14. Similarly, evidence
exists for both an association and lack of association between uNK cell number/function and
infertility 15,16,17,18. Only few studies have examined changes of uNK cell numbers in
endometriosis, demonstrating a lower percentage of CD56+ NK cells and a defect in NK
activity in the eutopic endometrium of women with endometriosis 19, 20, 21, 22. However
these studies did not focus on endometriosis patients with concomitant infertility disorders.
The aim of this study was to compare the expression of CD56, CD16, and NKp46 in the
eutopic endometrium from women with uRPL or UI to fertile patients, and correlate this
with the presence or absence of endometriosis.
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Sixty-one women were enrolled in the study. Twenty-one women had uRPL, 30 women had
UI, and 10 women had no history of infertility, recurrent pregnancy loss, or endometriosis
(controls). Among women with sub-fertility disorders, 13 women with uRPL and 23 with UI
had concomitant endometriosis diagnosed by laparoscopic procedure performed in selected
cases when clinical signs suggested the presence of the disease, either prior or post the
endometrial biopsy obtained for this study.
Sub-fertile subjects included women with UI and with 2 or more consecutive pregnancy
losses (uRPL) who were evaluated in the Division of Reproductive Endocrinology at
Greenville Hospital System in Greenville SC. Patients in the sub-fertility groups had regular,
ovulatory cycles, at least one patent fallopian tube (without hydrosalpinges) and were 40
years of age or younger. Exclusion criteria included known uterine fibroids or septum, a
history of pelvic inflammatory disease, PCOS or a partner with an abnormal semen analysis
(by the World Health Organization (WHO) criteria). While a prior history of minimal or
mild endometriosis was not an exclusion criterion, moderate or severe endometriosis was.
Unexplained RPL were excluded if they had a known thrombophilia, genetic or
immunologic abnormalities, or Müllerian defects. The fertile control group consisted of
subjects who were patients in the Department of Obstetrics and Gynecology at University of
North Carolina, Chapel Hill. All women who participated in the study signed an informed
consent that was approved by the Institution Review Board (IRB) of Greenville Hospital
System or University of North Carolina, Chapel Hill.
Tissue collection
All the participants underwent a standard endometrial biopsy by pipelle suction between
days 21 to 24 of the menstrual cycle based on urinary LH surge detection (LH plus 7 to 10
days). Each patient was provided with a urinary LH detection kit (Sepal Inc., Boston, MA)
and instructed to call the clinic with a positive LH surge. Tissue collected was submitted for
paraffin embedding for histologic determination, dating and immunohistochemistry analysis.
Women with maturational delay of endometrium (type I defect) were excluded from the
study 23, whereas a type 2 endometrial receptivity defect, based on the results of the αvβ3
integrin analysis, was found in 10 uRPL and 8 UI patients 24.
Immunohistochemistry
The expression of CD56, CD16, or NKp46 in all endometrial samples was determined by
immunohistochemistry. Endometrial samples were placed in 10% buffered formalin for 24
hours, dehydrated in graded ethanol, cleared in xylene and embedded in paraffin blocks.
Briefly, the tissues in paraffin blocks were cut into 5 μm thick sections using the Leica RM
2135 microtome and transferred onto glass slides. Tissues were dewaxed in xylene and
rehydrated through descending concentrated alcohols. Unmasking was performed in a 110V
pressure cooker in a preheated 1:100 antigen unmasking solution (Vector Laboratories,
Burlingame, CA) for 4 minutes. After washing, tissues were quenched in 3% hydrogen
peroxide diluted in methanol for 10 minutes. Slides were then washed in 1% PBS and
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blocked in 10% NGS blocking buffer (Vector Laboratories, Burlingame, CA) for 1 hour at
room temperature. Tissue sections were incubated with either monoclonal mouse anti-
human CD56 (NCAM) antibody at 1:50 dilution (Novocastra Leica Biosystem, Buffalo
Grove, IL, USA), monoclonal mouse anti-human CD16 antibody at a 1:20 dilution (AbD
Serotec, Raleigh, NC, USA), or monoclonal goat anti-human NKp46/NCR1 antibody at 1:25
dilution (R&D Systems, Minneapolis, MN, USA) at +4°C overnight in a humidified
chamber. Sections were washed extensively in 1% PBS and first incubated with the specific
secondary antibody for 1 hour at room temperature followed by an incubation with a 1:1000
streptavidin HRP substrate for 30 minutes at room temperature. The positive cells were then
visualized by incubation with DAB peroxidase solution (3.3′diaminobenzidene
terahydrochloride; Vector Laboratories, Burlingame, CA). Slides were counterstained with
haematoxylin (Biocare Medical), dehydrated in ascending concentrated alcohols, cleared in
xylene and mounted in Permount (Fisher Scientific). Replacing CD56, CD16, NKp46 or LIF
antibodies with an equivalent amount of control mouse IgG (Serotec) resulted in absence of
immunoreactivity. Decidual tissue and liver tissues from baboons were used as positive
controls at the same dilutions.
Analysis of images
Staining was assessed by using Olympus BH2 microscope (Olympus, Melville, NY, USA)
and 10 high-resolution images of each specimen were captured at 400x magnification with a
Nikon DS Fi1 digital camera/NIS Elements imaging software. The ratio between positive
CD16, CD56 or NKp46 cells (brown stain) and total endometrial stromal cells (blue stain)
was assessed using computer assisted image analysis with color deconvolution (Image J
software, NIH) for all the images. The investigators were blinded with respect to the
identification of the sections.
Statistical analysis
Data are expressed as average ± standard deviation of the mean (SD). Mann-whitney test
was used to compare data from women with uRPL or UI with data from fertile control
patients. Median values were calculated. Statistical significance was set at P<0.05.
Results
Clinical characteristics of study women
Sixty-one women were included in the study. Twenty-one had uRPL, 30 had UI, whereas 10
had no history of infertility, recurrent pregnancy loss, or endometriosis (controls).
Endometriosis was diagnosed in 36 sub-fertile women by laparoscopic procedure,
specifically in 13 uRPL and 23 UI women. The clinical characteristics of study women were
reported in Table 1. No significant differences were found in the age or BMI of women
between the groups.
Percentage of CD16, CD56, or NKp46 positive cells in the endometrium
The expression of CD16, CD56 or NKp46 in the endometrium was evaluated in women with
uRPL or UI with or without concomitant endometriosis, and fertile women using
immunohistochemistry. Representative staining is shown in Figures 1, 2, and 3. Following
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quantification, the average percent of endometrial stroma CD16+ cells was found to be
significantly higher in women with uRPL (7.9±3.2, p=0.03) and women with UI (9.0±5.5,
p=0.02) compared to fertile women (5.6±2.4) (Figure 1). In women with endometriosis
together with either uRPL or UI, the average percent of CD16+ cells was also significantly
higher than in fertile women (8.9±5.3 vs 5.6±2.4, p=0.01). No significant difference was
found between the average percent of CD16+ cells in women with uRPL compared to
women with UI.
The average percent of CD56+ cells in the endometrial stroma was trending lower, but not
significant, in women with uRPL (18.3±14.6), women with UI (18.4±16.4) and women with
endometriosis and UI or uRPL (18.4±15.4) compared to fertile women (22.3±19.9) (Figure
2). Conversely, the average percent of NKp46+ cells in the stroma was significantly higher
in women with uRPL (3.4±2.6, p=0.03) compared to fertile women (1.9±1.8) (Figure 3). No
significant difference was found between the average percent of NKp46+ cells in women
with UI (2.7±2.7) and women with endometriosis and either UI or uRPL (2.9±2.7)
compared to fertile women.
The ratio of the percent NKp46+ cells to the percent CD56+ cells in the endometrial stroma
was also calculated. In comparison to fertile women (0.1±0.1), the ratio of the percent
NKp46+:CD56+ cells was found to be significantly higher in women with uRPL (0.28±0.25,
p=0.005), women with UI (0.21±0.2, p=0.04), and women with endometriosis together with
either uRPL or UI (0.19±0.14, p=0.02) (Figure 4).
Discussion
A central regulator of the endometrial immune response is the natural killer cell. Uterine NK
cell phenotype and function differ from pNK cells; an increased intensity of CD56 (bright)
and a decreased expression of CD16 antigen 3 define the uNK cells, and, unlike pNK cells,
uNK cells are generally less cytotoxic 4. uNK cells are the most abundant leukocytes in the
human endometrium during the window of implantation and play a key role in the
maintenance of pregnancy as a result of the unique pattern of immune and angiogenic
factors released and due to their interactions with the trophoblast during the early gestation.
Our study has revealed that women with larger populations of cytotoxic CD16+ uNK cells,
in the absence of presence of endometriosis, may be considered at increased risk for UI and
uRPL. This finding is consistent with an association between uNK derangements and
infertility disorders postulated by previous studies. In fact, LaChapelle et al.10 observed a
predominant contingent of CD16+CD56dim cells and a significantly decreased
CD16−CD56bright cell subset in women with RPL compared to controls, while Quenby et
al. 11 reported an increased percentage of CD4+, CD14+,CD16+, CD56+ and MHC class II+
cells in women with RPL. In addition, Fukui et al. 15 observed an increase of the percentage
of CD16+CD56dim cells and decrease in the percentage of CD16−CD56bright cells in women
with infertility who miscarried after IVF cycles compared with women who delivered. Most
recently, Junovich et al.18 reported an increased number of CD16+ endometrial NK cells in
patients with unexplained infertility that correlated with a decrease in endometrial IL-6 and
VEGF levels. Therefore, it can be hypothesized that an increase in “activated” CD16+ uNK
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cells may create an unfavorable environment for implantation. The CD16+ uNK cells may
produce inflammatory cytokines and secrete cytotoxic factors in response to autologous
endometrial cells and fetal trophoblast cells, both of which could contribute to infertility or
spontaneous miscarriages.
Activity of both CD16+ and CD16− NK cells is controlled by a combination of receptors,
including the natural cytotoxicity receptor, NKp46. Our study suggests that having larger
populations of uterine NK cells with NKp46, in the absence or presence of endometriosis,
may also increase the risk of women experiencing uRPL and UI. Similarly, Zhang et al.25
reported higher expression of NKp46 on decidual NK cells from patients undergoing
spontaneous abortions. Engagement of NKp46 on decidual NK cells was observed by
Hicham et al.26 to increase cytotoxicity of decidual NK cells, and Yokota et al.27 recently
reported that NKp46 regulates cytokine production by endometrial NK cells. Thus, simlar to
CD16, the association between NKp46 and reproductive failure may relate to the increased
cytotoxic activity and dysregulation of cytokine production following engagement of
NKp46 on uterine NK cells. Since NKp46 is also expressed by certain populations of T
cells 28, it is possible that alterations in uterine T cells may also be contributing to
reproductive failure and endometriosis in our patients, but that is outside the scope of the
current study.
Contrary to previous data, our study suggests that the total number of CD56+ cells does not
seem to play a relevant role in distinguishing women with endometriosis with UI or uRPL
from fertile women. Instead, the data reported above suggests the ratio between CD56+ and
CD16+ cells and/or the ratio between CD56+ and NKp46+ cells, rather than the total number
of uNK cells, may be more important for maintaining a supportive environment for the
establishment of pregnancy. However, further investigation on larger populations of women
is needed to confirm this result.
The association between endometriosis and changes in the eutopic endometrium has been
recently reviewed 29. Although not well studied, endometriosis may be an underlying cause
of sub-fertility in both UI and uRPL by inducing changes in the eutopic endometrial
milieu 23, 29, 30, 31. In our prospectively obtained patient population, endometriosis was
found in the majority of women with UI and uRPL. The findings presented in this analysis
of uNK cells suggest that the difference between infertility and recurrent pregnancy loss
might represent a continuum of changes related to inflammatory influences of
endometriosis. While women with uRPL had higher levels of cytotoxic CD16+ uNK cells
compared to fertile women, the levels of CD16+ cells was even higher in women with UI,
although the increase was not statistically significant. A similar increase in dysfunction
comparing uRPL and UI was also demonstrated in a recent analysis of these samples for
αvβ3 integrin expression (Holoch et al. Hum Reprod, submitted 2013).
In conclusion, the results from our study support an association between the “activation”
status of uterine NK cells and an increased risk of reproductive failure in patients with and
without endometriosis. The increased CD16 and NKp46 recorded in patients with recurrent
pregnancy loss and patients with unexplained infertililty suggest that alterations in the
functions of uterine NK cells may occur either before implantation or during
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decidualization. In agreement with the recent reports by Seshadri et al.32 and Polanski et
al.33, the complex nature of uterine NK cells requires additional studies to determine which
measurements of uterine NK cell populations and/or functions can accurately predict the risk
of reproductive disorders in future patients, and also assist in determining the proper
treatment for those patients.
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(A) Percentage of CD16+ cells in endometrial stroma of women with unexplained recurrent
pregnancy loss (uRPL), unexplained infertility (UI) or with endometriosis associated with
either UI or uRPL, and in fertile women. (B) CD16 expression in the endometrium of
women with unexplained recurrent pregnancy loss (uRPL) or unexplained infertility (UI),
and fertile women. Staining with Mouse IgG also shown for negative control. CD16+ cells
are circled. (400x magnification).
*CD16 expression was significantly higher in women with uRPL (p=0.03), UI (p=0.01), or
endometriosis (p=0.01) compared to fertile women.
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(A) Percentage of CD56+ cells in endometrial stroma of women with unexplained recurrent
pregnancy loss (uRPL), unexplained infertility (UI) or with endometriosis associated with
either UI or uRPL, and in fertile women. (B) CD56 expression in the endometrium of
women with unexplained recurrent pregnancy loss (uRPL) or unexplained infertility (UI),
and fertile women. (400x magnification).
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(A) Percentage of NKp46+ cells in endometrial stroma of women with unexplained recurrent
pregnancy loss (uRPL), unexplained infertility (UI) or with endometriosis associated with
either UI or uRPL, and in fertile women. (B) NKp46 expression in the endometrium of
women with unexplained recurrent pregnancy loss (uRPL) or unexplained infertility (UI),
and fertile women. Staining with Goat IgG also shown for negative control. NKp46+ cells
are circled. (400x magnification).
*NKp46 expression was significantly higher in women with uRPL (p=0.03) compared to
fertile women.
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Ratio of NKp46+:CD56+ cells in endometrial stroma of women with unexplained recurrent
pregnancy loss (uRPL), unexplained infertility (UI) or with endometriosis associated with
either UI or uRPL, and in fertile women.
*Ratio of NKp46+:CD56+ cells was significantly higher in women with uRPL (p=0.005), UI
(p=0.04), or endometriosis (p=0.02) compared to fertile women.
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Table 1
Clinical profile of women enrolled in the study.
uRPL UI Fertile P*
Women (n) 21 30 10 -
Women with Endometriosis (n) 13 23 - -
Age (years) 34.2±3.0 31.9±4.3 30.4±8.0 0.07
Body mass index (Kg/m2) 26.3±7.3 23.4±6.9 22.2±1.4 0.14
Gravidity (n) 4.8±2.0 0.2±0.4 1.2±1.7 <0.05
Miscarriages (n) 4.2±1.9 - - -
Data are expressed as number (n) or mean ± standard deviation.
uRPL, unexplained recurrent pregnancy loss; UI, unexplained infertility.
*
T-test between study groups.
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